SG
Srinivas Guruprasad Nainar
About Srinivas Guruprasad Nainar
Data last updated:
Srinivas Guruprasad Nainar is a Director at Biolilly Pharma Private Limited (since 2026) and Director at Ebola Private Limited (since 2022). The companies operate in Internet.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biolilly Pharma Private Limited U46497AP2026PTC128254 | Director | 14 Sep 2026 | 2026 | Active | |
| Ebola Private Limited U74999AP2022PTC123119 | Director | 31 Oct 2022 | 2022 | Active |
Board colleagues of Srinivas Guruprasad Nainar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gollapalli Keerthy Sudha | 11945642 | Biolilly Pharma Private Limited | Director |
| Akhila Chagalamari | 09777345 | Ebola Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Guruprasad Nainar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Guruprasad Nainar
Srinivas Guruprasad Nainar currently holds 2 directorships: Biolilly Pharma Private Limited (Director, since 14 Sep 2026); Ebola Private Limited (Director, since 31 Oct 2022).
Srinivas Guruprasad Nainar was first appointed on 31 Oct 2022 as Director at Ebola Private Limited. The most recent appointment on record is 14 Sep 2026 at Biolilly Pharma Private Limited.
The current boards of Srinivas Guruprasad Nainar's companies include Gollapalli Keerthy Sudha (Biolilly Pharma Private Limited), Akhila Chagalamari (Ebola Private Limited).